A boost to its full-year outlook was lifting shares on Friday. Globus Medical guided for adjusted earnings between $3.75 and ...

Globus Medical (GMED) stock soars after strong Q3 earnings, leading Truist to upgrade the company to Buy from Hold. Read more ...

Shares of Globus Medical rose after the company's third-quarter results topped analyst estimates, driven by accelerated growth in its core spine business. The stock jumped 31% to $80.93 on Friday.

Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q3 CY2025, with sales up 22.9% ...

Globus Medical will hold a teleconference to discuss its third quarter 2025 results with the investment community at 4:30 p.m ...

Shares of Affirm Holdings (NASDAQ: AFRM) are up about 9%, or by $5.88 on the day. All thanks to solid earnings. EPS of 23 ...

Three stocks raised guidance after solid earnings. Will post-earnings optimism translate into short-term gains?

With U.S. stock markets set to open in two hours, Globus Medical Inc. (GMED) was up 28.1% in pre-market trading, and JFrog Ltd. (FROG) was up 22.8%.

Q3 2025 Management View CEO Keith Pfeil opened with, "We are extremely pleased with our overall Q3 performance, delivering sales of $769 million and non-GAAP diluted earnings per share of $1.18, ...

Analysts estimate that Globus Medical will report an earnings per share (EPS) of $0.78. Anticipation surrounds Globus Medical ...

Medical device company Globus Medical (NYSE:GMED) will be reporting results this Thursday after market hours. Here’s what ...

Globus Medical’s third quarter sales hit $760 million, a 22.9% increase year over year, according to financial results posted Nov. 6. Five things to know: 1. Revenue growth was driven by a 10% ...